MedPath

LGG/BB12-pastille Study

Phase 1
Completed
Conditions
Probiotics
Registration Number
NCT01577485
Lead Sponsor
University of Turku
Brief Summary

We want to study the effect of short-term consumption of probiotics (a mixture of L. rhamnosus GG and B. lactis BB-12)on the composition of the oral flora.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Subjects healthy, 20-30 yrs of age
Exclusion Criteria
  • Subjects not healthy, too old/young

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Counts of mutans streptococci4 weeks
Secondary Outcome Measures
NameTimeMethod
Amount of plaque4 weeks

Trial Locations

Locations (1)

Institute of Dentistry

🇫🇮

Turku, Finland

Institute of Dentistry
🇫🇮Turku, Finland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.